Maria Zannes, President and Chief Executive Officer: Ms. Zannes has more than 30 years of top executive-level management experience in industry. An attorney who specialized in regulatory law, she has worked as a top aide in the United States Congress, directed efforts leading to federal and state agency approvals, successfully lobbied numerous state legislatures, the Congress, and federal administrations. She was awarded the Lifetime Achievement Award by the American Society of Mechanical Engineers and Columbia University’s Earth Engineering Center Award. She is also the co-founder of two engineering research centers at Columbia University. Ms. Zannes received her J.D. from the University of Puget Sound in Washington State.
Steven Girgenti, Executive Chairman of the Board: Mr. Girgenti is a veteran healthcare executive with a foundation in healthcare marketing strategies, financing, and mergers and acquisitions. He founded and ran several successful businesses, including Healthworld Corporation, a leading global healthcare marketing services network with more than $1 billion in billings and 55 offices in 35 countries. Mr. Girgenti was recognized as “Entrepreneur of the Year” by NASDAQ, and was named Med Ad News’ first “Medical Advertising Man of the Year.” Currently, he serves as a Director of Vycor Medical and is the Vice Chairman of the Board of Governors of the Mount Sinai Hospital Prostate Disease and Research Center in New York City. Mr. Girgenti graduated from Columbia University and is a registered pharmacist.
Vivienne Rebel, M.D., Ph.D., Executive Vice President of Research and Development, Chief Medical and Science Officer: Dr. Rebel is a cancer (stem) cell biologist, with more than 20 years of experience in scientific research, focused on understanding the molecular events that lead to cancer development. She received her M.D. and Ph.D. from the Free University in Amsterdam (The Netherlands) and post-doctoral training at the Dana-Farber Cancer Institute, Harvard Medical School where she continued as a researcher and instructor. From 2005 to 2016, she led her own research group at The UT Health Science Center at San Antonio and in 2012 received the Cancer Therapy and Research Center Discovery of the Year Award. She is the (co)author of more than 40 publications in peer-reviewed journals including Cell and Science.
William Bauta, Ph.D., Senior Vice President of Research and Development, Therapeutics: Dr. Bauta is a medicinal chemist with more than 25 years of experience in discovery, development and commercialization of pharmaceuticals to treat oncology, virology, neuroscience, immunology and metabolic diseases. He joins bioAffinity Technologies from Southwest Research Institute where he helped develop the Institute’s pharmaceuticals services and bioengineering business. Dr. Bauta was Associate Director of Science at Genzyme Corporation and held a similar position at Ilex Products, Inc., where he was responsible for the discovery, development and FDA approval of multiple therapeutics. He holds several patents and has published in the journal Science and more than a dozen other scientific journals and conference proceedings. Dr. Bauta received his Ph.D. from the University of Chicago.